2018 Beacon Meeting Archive

Posted on December 31, 2018 by Beacon Angels

During 2018 Beacon Angels entertained new funding proposals from companies and due diligence reports, respectively, as follows :

January 9, 2018

  • Meenta which helps scientists more fully access costly and limited laboratory resources by finding, accessing and sending biological samples to idle equipment via the Cloud; and
  • Tӧst Beverages, which develops and sells uniquely delicious non-alcoholic celebratory beverages.

February 13, 2018

  • Jobletics, an on-demand temp staffing marketplace for the food service and hospitality industry, and
  • Name Net Worth, which offers an app to convert your networking activity into sales opportunities.

Members’ due diligence reports: Magurobotics, and Töst Beverages. 

March 13, 2018

  • GoPetie, a B2B & B2C mobile platform that connects pet owners to each other, to local service providers and municipalities in a social community environment, and
  • GuruSnaps, which connects business owners with professionals (Gurus) who can help them sell their business on the best terms.

Members’ due diligence reports: Töst and Jobletics.

April 10, 2018

  • Rockstep Solutions, which offers Climb, a scalable SaaS animal laboratory informatics software product that is designed in the Azure™ Cloud to leverage smart-lab technologies and utilize more elastic resources.

Due diligence update: Tӧst,

Beacon hosted funding updates by the CEOs of Pykus Therapeutics, and Spiro Technologies.

May 8, 2018

  • Zippity Cars, which offers maintenance services directly to car owners at their place of business,
  • BioTrak Therapeutics, which offers a mobile behavioral health app for the 2.4 billion people worldwide who suffer from frequently recurring tension-type headaches & migraines, and
  • ScholarJet, where students earn college scholarships and companies reach a talented pool of college students, vet candidates for internships and employment, and enhance their employer brand.

We heard an update on Meenta, a prior Beacon presenter.

June 12, 2018

  • LASO Technologies, which is selling a very waterproof Iphone case and is developing other field-use Iphone accessories; and
  • ENTERAstim, which is developing a therapeutic system to stimulate the small bowel in the human GI tract electrically and speed the return of its motility from ileus to normal.

We also heard:

  • Due diligence reports on Zippity Cars and on ScholarJet, and
  • An update from the CEO and founder of portfolio company Ecare Vault.

Finally, we conducted a full review of the health and prospects of the companies in the Beacon Angels portfolio.

July 10, 2018

  • Waec, which provides a low-cost, efficient local delivery option for consumers and stores using autonomous ground drones that politely navigate sidewalks and crosswalks, and
  • Mobile Price Card is which offers a patent-pending technology to help consumer electronics retailers improve sales by advertising on the screens of devices already on display.

September 11, 2018

  • QMedic, which offers a smart emergency help button service partnered with health insurers to support high-risk members living at home; and
  • Datarista, a platform for data providers in the third-party Sales & Marketing data industry to create and manage integrations in CRM and Marketing Automation platforms such as Salesforce, Marketo & Eloqua.

Member reports:

  • Beacon’s participation in any extension of the Zippity round; and
  • Update on the pending bridge round by Siamab Therapeutics.

October 9, 2018

  • Omega Trace, which is offering a product suite for brick and mortar businesses to monitor and track visitors to their premises, and
  • Weft-Tex, which has developed and is selling a proprietary breath-through crib mattress.

Member updates and due diligence: Datarista, and Zippity Cars.

November 13, 2018

  • First Light Biosciences, which has developed and will be bringing to market a self-contained benchtop system to diagnose antibiotic-resistant infections in hospitals; and
  • Enviro Power, which has developed the SmartWatt™ Boiler, a 95% efficient, closed-loop micro steam turbine for heating systems in homes and businesses to generate electric power on-site both as a backup and more cheaply than grid-supplied power.

Members’ due diligence reports and company updates:

  • Datarista, a platform in the third-party Sales & Marketing data industry for data providers to create and manage integrations in CRM and Marketing Automation platforms such as Salesforce, Marketo & Eloqua; and
  • Concrete Sensors, which is selling a system for building professionals to monitor and control the concrete curing process.

December 11, 2018

  • Invitrometrix, which has developed and is selling devices to life science research and drug discovery companies that uniquely provide continuous, real-time, quantitative monitoring of cells in culture, and
  • Walch High School Math, which automates the development and deployment of high school curricula, giving school districts a virtual curriculum department in the cloud.

Member Due Diligence:

  • Datarista, which offers a data platform for the Sales & Marketing data industry; and
  • First Light Biosciences, which has developed and will be bringing to market a self-contained benchtop system for the on-site diagnosis of antibiotic-resistant infections in hospitals.
Posted in Beacon Angels Events, Funding Presentations, Past Beacon Meetings | Tagged , , , | Leave a comment

TerraFlow & CellField Technologies

Posted on October 10, 2024 by Angel Treaty

Beacon conducted the following business at its October 8, 2024 meeting:

We entertained funding proposals from the following: 

  • TerraFlow, selling to pharma companies a blood-to-biomarker discovery engine that delivers a complete immunophenotyping report in 24 hours; and
  • CellField Technologies, developing a patented system for drug development companies to test drug efficacy on human joint tissues without animal testing.

We entertained a portfolio company update from:

  • Jaia Robotics, delivering low-cost, micro-sized, high-speed Aquatic Drones for data collection and payload delivery.

Members reported on current funding rounds:

  • S129 – QSM Diagnostics,
  • S130 – Surgicure &
  • S131 – Pykus Therapeutics.
Posted in Past Beacon Meetings | Tagged , , , | Leave a comment

FreezeNit, AiM Medical Robotics

Posted on September 10, 2024 by Angel Treaty

At its meeting on September 10, 2024, Beacon Angels conducted the following business:

We entertained new funding presentations as follows:

  • FreezeNit, a patent-pending technology that kills head lice and nits using only cold CO2 gas without the need for harmful pesticides, or messy prescriptions; and
  • AiM Medical Robotics, a neurosurgical robotics company commercializing a unique compact MRI-compatible surgical robot for brain surgery.

Beacon portfolio update:

  • Pykus Therapeutics, developing a better means to secure the retina following reattachment surgery.

Report on companies in due diligence:

  • ClearCut Surgical, developing electrocautery surgeons’ tools that incorporate smoke evacuation, fluid suction, and blunt dissection.
  • WAHTS Hearing.

Report on pending funding rounds by Series number.

  • 129 QSM Diagnostics, delivering rapid diagnostic test kits and devices to pet owners and veterinarians.
  • 130 Surgicure, a medical device company that is innovating airway management for civilian and military use; and
  • 131 Pykus.
Posted in Past Beacon Meetings | Tagged , , , | Leave a comment

SplitBrick, ClearCut Surgical & Surgicure

Posted on July 9, 2024 by Angel Treaty

Beacon Angels undertook the following at its meeting on July 9, 2024:

We entertained new funding presentations as follows:

  • SplitBrick, offering a platform for fractional real estate investing with low-commission trading of any property for sale nationwide.
  • ClearCut Surgical, developing electrocautery surgeon’s tools that incorporate smoke evacuation, fluid suction, and blunt dissection.
  • Surgicure, a medical device company innovating airway management for civilian and military use.

Members reported on pending funding rounds, by Series number.

  • 116C Realplay bridge note;
  • 128 AI Lean, developing software to automate the lien-to-auction process for self-storage owners;
  • 129 Neosoma, developing a SAAS clinical management platform for neuro-oncology; and
  • 130 QSM Diagnostics, delivering rapid diagnostic tests.

Posted in Past Beacon Meetings | Tagged , , | Leave a comment

WAHTS Hearing, DeepLook Medical & RelayVoice

Posted on June 11, 2024 by Angel Treaty

At the Beacon Angels meeting on June 14, 2024, we undertook the following activities:

We entertained new funding presentations as follows:

  • WAHTS Hearing, offering a proprietary wireless headset to enable a person’s hearing to be tested from any location;
  • DeepLook Medical, offering FDA-approved shape-recognition software for better screening, diagnosis and treatment of breast cancer via dense mammography; and
  • RelayVoice, personalizing volume phone calls to enable highly personalized voicemail drops at scale.

Members reported on pending and closed funding rounds, by Series number:

  • 126 myBiometry developing an advanced early-warning system for asthma attacks; and
  • 128 AI Lean, offering a software system for the self-storage operator to manage its liens and conduct its auctions.

Members reported on companies in due diligence:

  • AI Lean; and
  • AGED Diagnostics.

Posted in Past Beacon Meetings | Tagged , , | Leave a comment

Relavo & EMBioSys

Posted on May 14, 2024 by Angel Treaty

At the Beacon Angels meeting on May 14, 2024, we conducted the following business.

We entertained funding presentations from the following:

  • Relavo, developing a self-disinfecting connection device for kidney failure patients to receive peritoneal dialysis (PD) safely and at home; and
  • EMBioSys, developing therapeutic wearable garments to treat solid metastatic cancers with low level induced electric fields (iEFs).

We also heard Beacon portfolio updates and follow-up presentations as follows:

  • QSM Diagnostic (Edgar Goluch), selling diagnostic mail-in kits for veterinarians rapidly and accurately to diagnose bacterial infections in pets; and
  • Zeptive, selling patented battery-powered and wireless vape/smoke & safety sensors for schools to detect risky behavior without cameras.

Members reported on pending and closed funding rounds, by Series number:

  • 126 myBiometry developing an advanced early-warning system for asthma attacks.
  • 112B Theromics, developing tumor-targeting therapies;
  • 116B Realplay, providing video highlights for youth sports; and
  • 122 GelMEDIX improving drug delivery for the eye.

Members reported on companies in due diligence:

  • AI Lean; and
  • AGED Diagnostics.
Posted in Past Beacon Meetings | Tagged , , | Leave a comment

AGED Diagnostics, Vuja De Sciences & PneumoNIX Medical

Posted on April 9, 2024 by Angel Treaty

At the Beacon Angels meeting on April 9, 2024, we entertained new funding presentations as follows:

  • AGED Diagnostics (Rachel Zayas – a pre-clinical diagnostics venture developing blood tests for fatty liver disease and liver fibrosis.
  • Vuja De Sciences – providing a novel approach to prevent cancer recurrence and progression.
  • PneumoNIX Medical – offering a product to eliminate complications of tissue biopsy by sealing the biopsy track at the outset.

Members reported on companies in due diligence:

  • Surgicure Technologies,
  • Glycologix,
  • Agile Devices &
  • AI Lean.

Posted in Past Beacon Meetings | Tagged , , | Leave a comment

Glycologix, Agile Devices & AI Lean

Posted on March 12, 2024 by Angel Treaty

At the Beacon Angels meeting on Tuesday, March 12, 2024, we entertained new funding presentations as follows:

  • Glycologix, developing, GLX-100, a biopolymer medical device for the novel treatment of the underserved millions with interstitial cystitis/bladder pain syndrome.
  • Agile Devices, which has developed the FDA-cleared Angler® Steerable and Deflectable Microcatheter, a novel device with a fully intraoperative active tip control for neurovascular, coronary and peripheral use cases; and
  • AI Lean, which outsources the lien-to-auction process for self-storage owners, automating collections, liens and auctions management.

Members reported on pending funding rounds, by Series number.

  • 112B Theromics, developing tumor-targeting therapies ($30K held);
  • 116B Realplay, providing video highlights for youth sports ($40K invested)
  • 122 GelMEDIX improving drug delivery for the eye ($190k invested, of which $76K held in escrow); and
  • 126 myBiometry developing an advanced early-warning system for asthma attacks ($35K held awaiting company docs).

Members reported on companies in due diligence:

  • Surgicure Technologies, developing a device to improve intubation quality and safety.

Members reported on pending funding rounds, by Series number.

  • 112B Theromics, developing tumor-targeting therapies;
  • 116B Realplay, providing video highlights for youth sports;
  • 122 GelMEDIX improving drug delivery for the eye; and
  • 126 myBiometry developing an advanced early-warning system for asthma attacks ($35K held awaiting company docs).
Posted in Past Beacon Meetings | Tagged , , , | Leave a comment

Ankored & Robotics88

Posted on February 13, 2024 by Angel Treaty

Beacon Angels members conducted the following new business at its meeting on Tuesday, February 13, 2024:

We entertained new funding proposals from the following:

  • Ankored (Seth Lieberman, providing an automated tracking platform designed for small to mid-sized organizations to streamline their compliance, including document collection, clearances, training, certificates, approvals, and audit logs.
  • Robotics88, delivering aerial drones along with a mapping service subscription to land managers who conduct prescribed burns. The drones provide pre-burn fire prediction in the planning stage and post-burn objective evaluation.

We heard updates from the Beacon portfolio company,

  • NF2 Therapeutics, developing gene replacement therapy to prevent deafness, loss of mobility and devastating NF2 brain tumors and a targeted antibody-drug conjugate to treat NF2 meningiomas.

Swiggart reported on funding rounds, by Series number, as follows.

Completed

  • 123 Xeno (Series A ext’n $1.0 MM new money, $1.5 MM debt conversion) (PR=$85K; $177K invested);

Pending

  • 112B Theromics developing tumor-targeting therapies (30K invested);
  • 122 GelMEDIX (PR=$223K; $190K collected);
  • 126 Mybiometry (Smith) offering early warning of asthma attacks up to 20 days in advance using intelligent diagnostics and connected monitoring ($35K collected).

Members reported on companies in due diligence:

  • RealNose (Jim Doscher)) offers AI-trained, bio-programmable olfactory sensors that map scent profiles, initially to help doctors detect prostate cancer in patients.
  • RestauRent (DD by Smith, Doscher & Jack Wagner), a B2B SAAS platform to directly book private events at venues that have event space for 15-300+ guests.
Posted in Past Beacon Meetings | Tagged , , | Leave a comment

Predictive Healthcare & Verisense Health

Posted on January 9, 2024 by Beacon Angels

Beacon Angels members conducted the following new business at its meeting on Tuesday, January 9, 2024:

We entertained new funding proposals from the following:

  • Predictive Healthcare, of Bedford, MA develops and markets a predictive postoperative patient wound healing outcome digital platform called MyHealthPal.
  • Verisense Health, which provides digital health management services via proprietary wearable sensors.

We heard a follow-on funding presentation:

  • Realplay, offering AI-driven sports video solutions for youth baseball and softball complexes. Selling B2B systems with a B2C subscription platform for players, parents, fans, coaches and scouts.

We considered multiple funding rounds, by Series number:

Completed

  • 124 Jaia Robotics.
  • 125 Imago Rehab.

Pending

  • 112B Theromics, developing tumor-targeting therapies;
  • 122 GelMEDIX, developing gel-form eye therapies; and
  • 123 Xeno, developing a weight-loss pill; and
  • 126 Mybiometry, offering early warning of asthma attacks up to 20 days in advance using intelligent diagnostics and connected monitoring.

Members reported on companies in due diligence:

  • RealNose, offers AI-trained, bio-programmable olfactory sensors that map scent profiles, initially to help doctors detect prostate cancer in patients.
  • RestauRent, a B2B SAAS platform to directly book private events at venues that have event space for 15-300+ guests.
Posted in Past Beacon Meetings | Tagged , , , | Leave a comment

Zelegent & RealNose

Posted on December 12, 2023 by Angel Treaty

At its meeting on Tuesday, October12, 2023, Beacon Angels members entertained new funding proposals from the following:

  • Zelegent (David Elliot) has developed and launched an FDA-cleared Elevo® Snoring Intervention Set for doctors to treat patients in their offices with Elevoplasty® for mild to moderate snoring.
  • RealNose (Nikolas Stefanou) offers AI-trained, bio programmable olfactory sensors that map scent profiles, initially to help doctors detect prostate cancer in patients.

We heard a follow-on funding presentation:

  • QSM Medical sells diagnostic mail-in kits and instruments to veterinarians. These kits and instruments enable pet owners to obtain diagnostic testing results faster.

Members reported on companies now in due diligence: 

Conversifi, which assists language learners, who collectively spend $90B a year, to learn to speak another language, by providing on-demand immersive live chat with native speakers.

NED Medical, developing CombiSphere to co-administer chemoradiotherapy at liver tumor sites and thus lower side effects and improve outcomes; and

myBiometry, offering early warning of asthma attacks up to 20 days in advance using intelligent diagnostics and connected monitoring. They are closing out a round that includes Launchpad Ventures and Cherrystone.

Posted in Uncategorized | Leave a comment